We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

81 hedge funds and large institutions have $82.2M invested in Palvella Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% less ownership

Funds ownership: 0.75% → 0.72% (-0.03%)

2% less capital invested

Capital invested by funds: $83.6M → $82.2M (-$1.4M)

1% less funds holding

Funds holding: 82 → 81 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

24% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 29

Holders
81
Holders Change
-1
Holders Change %
-1.22%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
22
Reduced
29
Closed
7
Calls
$55K
Puts
–
Net Calls
+$55K
Net Calls Change
+$111K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$734K
2
Cerity Partners
Cerity Partners
New York
+$492K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$396K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$350K
5
SFM
Sphera Funds Management
Israel
+$273K

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$1.79M
2
OFM
Omega Fund Management
Massachusetts
-$1.43M
3
TCM
Tekla Capital Management
Massachusetts
-$1.16M
4
Renaissance Technologies
Renaissance Technologies
New York
-$261K
5
Millennium Management
Millennium Management
New York
-$235K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$555K +$79.8K +365 +16%
JP Morgan Chase
27
JP Morgan Chase
New York
$499K +$8.31K +38 +2%
Cerity Partners
28
Cerity Partners
New York
$489K +$492K +2,250 +1,744%
N
29
Nuveen
North Carolina
$428K +$3.28K +15 +0.7%
CHAM
30
Clear Harbor Asset Management
Connecticut
$391K -$40.7K -186 -9%
SO
31
STRS Ohio
Ohio
$359K – – –
Charles Schwab
32
Charles Schwab
California
$353K +$25.6K +117 +7%
Los Angeles Capital Management
33
Los Angeles Capital Management
California
$323K -$9.4K -43 -3%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$318K -$5.25K -24 -2%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$258K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$246K -$27.3K -125 -9%
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$232K -$178K -813 -42%
6CM
38
683 Capital Management
New York
$231K – – –
CS
39
Credit Suisse
Switzerland
$209K -$26K -119 -10%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$204K – – –
GCP
41
GSA Capital Partners
United Kingdom
$201K +$214K +979 New
Bank of America
42
Bank of America
North Carolina
$186K +$76.3K +349 +63%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$162K +$219 +1 +0.1%
William Blair & Company
44
William Blair & Company
Illinois
$154K +$27.3K +125 +20%
UBS Group
45
UBS Group
Switzerland
$149K -$3.06K -14 -2%
AllianceBernstein
46
AllianceBernstein
Tennessee
$149K – – –
SCM
47
Silverarc Capital Management
Massachusetts
$129K +$137K +625 New
AQR Capital Management
48
AQR Capital Management
Connecticut
$126K -$136K -620 -50%
Barclays
49
Barclays
United Kingdom
$114K +$10.3K +47 +9%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$99K – – –
1
2
3 4

PVLA Hedge Fund Activity: Q1 2021 in Review

81 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q1 2021, worth a combined $82.2M — down 1.7% from $83.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PVLA and 6 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 22 added.

The largest buyer was Wells Fargo, adding an estimated $734K. The largest seller was Woodline Partners, cutting an estimated $1.79M.

  • 81 institutional investors held Palvella Therapeutics (PVLA) as of Q1 2021, down from 82 in Q4 2020.
  • Funds reported $82.2M of Palvella Therapeutics stock for Q1 2021, down 1.7% quarter-over-quarter.
  • 6 funds opened new Palvella Therapeutics positions in Q1 2021 and 7 closed out, a net change of -1 holder.
  • The largest Palvella Therapeutics buyer in Q1 2021 was Wells Fargo, an estimated $734K added.
  • The largest Palvella Therapeutics seller in Q1 2021 was Woodline Partners, an estimated $1.79M sold.

Based on aggregated 13F filings for Q1 2021.